What does FARMAKON do?

FARMAKON is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 23 February 1999, 1 establishment.

What is the address of FARMAKON?

The registered office of FARMAKON is located at Kerkstraat 107, 9255 Buggenhout.

Is FARMAKON still active?

Yes. According to the CBE (31 October 2026) FARMAKON is active, legal situation “Normale toestand”, started on 23 February 1999.

Is FARMAKON registered on Peppol?

Yes, FARMAKON is registered on the Peppol network with ID 0208:0465507453.

What is the enterprise number of FARMAKON?

The enterprise number of FARMAKON is BE0465507453.

When was FARMAKON founded?

FARMAKON was founded on 23 February 1999.

Who are the directors of FARMAKON?

According to the 2025 annual accounts, the directors of FARMAKON are: Daniël Bresseleers.

Is FARMAKON a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 February 1999; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did FARMAKON make in 2025?

FARMAKON posted a profit after taxes of € 55,869 in financial year 2025.

What is the revenue of FARMAKON?

As a small company, FARMAKON is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 84,101.

FARMAKON (Private Limited) - Buggenhout - BE0465507453

Dossier FARMAKON, printed on 31 October 2026 from databakkes.be/en/0465507453/farmakon. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

FARMAKON from Buggenhout, company number BE0465507453, closed financial year 2025 with a result of € 55,869 after tax. For that financial year FARMAKON recorded a gross margin of € 84,101 and equity of € 680,844. Compared with financial year 2024, the result moved from € 59,324 to € 55,869. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.

What it is worth Growing

€ 680,844

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 55,869

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 27,097

▼ 89% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 55,789 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,139

▲ € 1,876 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 19,326

▼ 33% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 86,835 Gross margin 2022: € 86,835 First fiscal year in the series	€ 84,464 Gross margin 2023: € 84,464 ▼ 3% vs 2022 (€ 86,835) Unfavourable step	€ 84,751 Gross margin 2024: € 84,751 Unchanged (€ 84,464) Favourable step	€ 84,101 Gross margin 2025: € 84,101 ▼ 1% vs 2024 (€ 84,751) Unfavourable step	▼ 1%
Profit after taxes	€ 60,930 Profit after taxes 2022: € 60,930 First fiscal year in the series	€ 143,666 Profit after taxes 2023: € 143,666 ▲ 136% vs 2022 (€ 60,930) Favourable step	€ 59,324 Profit after taxes 2024: € 59,324 ▼ 59% vs 2023 (€ 143,666) Unfavourable step	€ 55,869 Profit after taxes 2025: € 55,869 ▼ 6% vs 2024 (€ 59,324) Unfavourable step	▼ 6%
Equity	€ 594,295 Equity 2022: € 594,295 First fiscal year in the series	€ 678,441 Equity 2023: € 678,441 ▲ 14% vs 2022 (€ 594,295) Favourable step	€ 680,765 Equity 2024: € 680,765 Unchanged (€ 678,441) Favourable step	€ 680,844 Equity 2025: € 680,844 Unchanged (€ 680,765) Favourable step
Total debts	€ 35,278 Total debts 2022: € 35,278 First fiscal year in the series	€ 36,227 Total debts 2023: € 36,227 ▲ 3% vs 2022 (€ 35,278) Unfavourable step	€ 36,569 Total debts 2024: € 36,569 ▲ 1% vs 2023 (€ 36,227) Unfavourable step	€ 55,579 Total debts 2025: € 55,579 ▲ 52% vs 2024 (€ 36,569) Unfavourable step	▲ 52%
Cash	€ 175,261 Cash 2022: € 175,261 First fiscal year in the series	€ 260,775 Cash 2023: € 260,775 ▲ 49% vs 2022 (€ 175,261) Favourable step	€ 252,652 Cash 2024: € 252,652 ▼ 3% vs 2023 (€ 260,775) Unfavourable step	€ 27,097 Cash 2025: € 27,097 ▼ 89% vs 2024 (€ 252,652) Unfavourable step	▼ 89%
Retained profit	€ 575,695 Retained profit 2022: € 575,695 First fiscal year in the series	€ 659,841 Retained profit 2023: € 659,841 ▲ 15% vs 2022 (€ 575,695) Favourable step	€ 662,165 Retained profit 2024: € 662,165 Unchanged (€ 659,841) Favourable step	€ 662,244 Retained profit 2025: € 662,244 Unchanged (€ 662,165) Favourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 59,520 Dividend 2023: € 59,520 Unchanged (€ 0) Unchanged	€ 57,000 Dividend 2024: € 57,000 ▼ 4% vs 2023 (€ 59,520) Unchanged	€ 55,789 Dividend 2025: € 55,789 ▼ 2% vs 2024 (€ 57,000) Unchanged	▼ 2%
Bank debt	€ 6,735 Bank debt 2022: € 6,735 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 6,735) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 629,573 Balance sheet total 2022: € 629,573 First fiscal year in the series	€ 714,668 Balance sheet total 2023: € 714,668 ▲ 14% vs 2022 (€ 629,573) Unchanged	€ 717,334 Balance sheet total 2024: € 717,334 Unchanged (€ 714,668) Unchanged	€ 736,423 Balance sheet total 2025: € 736,423 ▲ 3% vs 2024 (€ 717,334) Unchanged	▲ 3%

Key figures of FARMAKON, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to FARMAKON?

What happened at FARMAKON in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 18, 2026 New annual accounts for financial year 2025: profit of € 55,869 (▼ 6% vs 2024). filed late Source: NBB ↗
Nov 9, 1999 New establishment in Buggenhout. KBO
Feb 23, 1999 Start of the company according to the CBE. KBO

In short

From € 60,930 profit in 2022 to € 55,869 profit in 2025.

Paid € 109,095 in corporate taxes since 2022.

Best year ever: 2023, with € 143,666 profit.

Paid out € 172,309 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Daniël Bresseleers

FARMAKON

Apotheek Bresseleers-Van der Cruyce

Behind FARMAKON is Daniël Bresseleers. Daniël Bresseleers is also behind Apotheek Bresseleers-Van der Cruyce.

Directors

According to the 2025 annual accounts

Daniël Bresseleers

Manager

Also active at: Apotheek Bresseleers-Van der Cruyce

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkstraat 107

9255 Buggenhout

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Apotheek Bresseleers-Van der Cruyce same network

€ 132,124 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0465.507.453

VAT number

BE 0465.507.453

Registered office

Kerkstraat 107, 9255 Buggenhout

Names & denominations

FARMAKON

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 February 1999

Peppol

Active · Active since 27 Nov 2025

Activities · NACE

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

FARMAKON

Financials

What happened to FARMAKON?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions